Clinical trial reportCancerPublished
Olaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall survival analysis
Regional connection
Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source
- Institution
- University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Ovarian Neoplasms; Neoplasm Recurrence, Local; Piperazines; Phthalazines; BRCA1 Protein; BRCA2 Protein; Prospective Studies; Mutation; Germ-Line Mutation; Adult; Aged
- PubMed ID
- 39817648
- PubMed Central ID
- PMC11736996
- Open access
- Yes, open
- Added to directory
- Source checked